Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Chanez

Showing results (101-110 of 238) with videos related to

Pageof 24
Sort By:
Pharmacology & Therapeutics|October 9, 2017
Lung development, regeneration and plasticity: From disease physiopathology to drug design using induced pluripotent stem cellsEngi Ahmed, Caroline Sansac, Said Assou, et al.
Pulmonary Pharmacology & Therapeutics|November 8, 2006
Safety, tolerability and efficacy of indacaterol, a novel once-daily beta(2)-agonist, in patients with COPD: a 28-day randomised, placebo controlled clinical trialJutta Beier, Pascal Chanez, Jean-Benoit Martinot, et al.
Frontiers in Immunology|March 18, 2017
Bronchial Epithelial Cells from Asthmatic Patients Display Less Functional HLA-G Isoform ExpressionFederico Carlini, Christophe Picard, Céline Garulli, et al.
Clinical Reviews in Allergy & Immunology|April 13, 2017
Cypress Pollinosis: from Tree to ClinicDenis Charpin, Christian Pichot, Jordina Belmonte, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|October 1, 2009
Non-invasive markers of airway inflammation and remodeling in childhood asthmaRosalia Gagliardo, Stefania La Grutta, Pascal Chanez, et al.
Lancet (London, England)|August 21, 2012
Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trialIan D Pavord, Stephanie Korn, Peter Howarth, et al.
Respiratory Medicine|November 22, 2019
Baseline blood eosinophil count as a predictor of treatment response to the licensed dose of mepolizumab in severe eosinophilic asthmaFrank C Albers, Christopher Licskai, Pascal Chanez, et al.
Presse Medicale (Paris, France : 1983)|August 22, 2016
[How to consider triggers and comorbid conditions in severe asthma in adults]Cindy Barnig, Martin Veaudor, Clarisse Gautier, et al.
American Journal of Respiratory and Critical Care Medicine|December 16, 2014
Reduction of airway smooth muscle mass by bronchial thermoplasty in patients with severe asthmaMarina Pretolani, Marie-Christine Dombret, Gabriel Thabut, et al.
Biochemical and Biophysical Research Communications|March 19, 2022
Using intracellular SCGB1A1-sorted, formalin-fixed club cells for successful transcriptomic analysisCharlotte Vernisse, Aurélie Petit, Véronique Pantesco, et al.
Pageof 24

Showing results (101-110 of 238) with videos related to

Sort By:
Pageof 24
Pharmacology & Therapeutics|October 9, 2017
Lung development, regeneration and plasticity: From disease physiopathology to drug design using induced pluripotent stem cellsEngi Ahmed, Caroline Sansac, Said Assou, et al.
Pulmonary Pharmacology & Therapeutics|November 8, 2006
Safety, tolerability and efficacy of indacaterol, a novel once-daily beta(2)-agonist, in patients with COPD: a 28-day randomised, placebo controlled clinical trialJutta Beier, Pascal Chanez, Jean-Benoit Martinot, et al.
Frontiers in Immunology|March 18, 2017
Bronchial Epithelial Cells from Asthmatic Patients Display Less Functional HLA-G Isoform ExpressionFederico Carlini, Christophe Picard, Céline Garulli, et al.
Clinical Reviews in Allergy & Immunology|April 13, 2017
Cypress Pollinosis: from Tree to ClinicDenis Charpin, Christian Pichot, Jordina Belmonte, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|October 1, 2009
Non-invasive markers of airway inflammation and remodeling in childhood asthmaRosalia Gagliardo, Stefania La Grutta, Pascal Chanez, et al.
Lancet (London, England)|August 21, 2012
Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trialIan D Pavord, Stephanie Korn, Peter Howarth, et al.
Respiratory Medicine|November 22, 2019
Baseline blood eosinophil count as a predictor of treatment response to the licensed dose of mepolizumab in severe eosinophilic asthmaFrank C Albers, Christopher Licskai, Pascal Chanez, et al.
Presse Medicale (Paris, France : 1983)|August 22, 2016
[How to consider triggers and comorbid conditions in severe asthma in adults]Cindy Barnig, Martin Veaudor, Clarisse Gautier, et al.
American Journal of Respiratory and Critical Care Medicine|December 16, 2014
Reduction of airway smooth muscle mass by bronchial thermoplasty in patients with severe asthmaMarina Pretolani, Marie-Christine Dombret, Gabriel Thabut, et al.
Biochemical and Biophysical Research Communications|March 19, 2022
Using intracellular SCGB1A1-sorted, formalin-fixed club cells for successful transcriptomic analysisCharlotte Vernisse, Aurélie Petit, Véronique Pantesco, et al.
Pageof 24